Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eric A. Klein
Observed names:
Eric A Klein,
Eric Klein,
Erick A. Klein
Observed institutions:
Cleveland Clinic,
Grail (United States)
ORCID:
0009-0009-1443-7549
Observed ORCIDs:
0009-0009-1443-7549,
0000-0002-1783-0698
OpenAlex ID:
A5111610389
State T1–2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy
1997
·
Patrick A. Kupelian
, Jerald Katcher
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
205
Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostate
2000
·
Janice A Lyons
, Patrick A Kupelian
, et al.
·
Urology
·
128
Tumor Markers in Testis Cancer
1993
·
Eric A. Klein
·
Urologic Clinics of North America
·
71
Initial Dissection of the Lateral Fascia Reduces the Positive Margin Rate in Radical Prostatectomy
1998
·
Eric A Klein
, Patrick A Kupelian
, et al.
·
Urology
·
58
Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone
1997
·
Jerald Katcher
, Patrick A. Kupelian
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
53
The Prostate Cancer Prevention Trial: Current status and lessons learned
2001
·
Ian M Thompson
, Margaret Kouril
, et al.
·
Urology
·
42
Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations
2001
·
Ronald Lieberman
, William G Nelson
, et al.
·
Urology
·
26
PDF
Open technique for nerve-sparing retroperitoneal lymphadenectomy
2000
·
Eric A Klein
·
Urology
·
13
Locally advanced prostate cancer
2001
·
Eric A. Klein
, Patrick A. Kupelian
, et al.
·
Current Treatment Options in Oncology
·
10
Testicular cancer in association with developmental renal anomalies and hypospadias
1996
·
Eric A. Klein
, Roland N. Chen
, et al.
·
Urology
·
8
Partial and Total Penectomy for Cancer
1991
·
Eric A. Klein
·
Urologic Clinics of North America
·
8
Retroviral transduction of intercellular adhesion molecule-1 enhances endothelial attachment of bladder cancer
1997
·
Kazunari Tanabe
, Jeannine P. Alexander
, et al.
·
Urological Research
·
6
Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study
2025
·
Catherine R. Marinac
, Charles H. McDonnell
, et al.
·
Cancer Prevention Research
·
5
PDF
Modeled Benefit of Individual Cancer Signal Origin Prediction for Multi-Cancer Early Detection
2025
·
Eric A. Klein
, Timothy R. Church
, et al.
·
Cancer Research Communications
·
2
Abstract 864: Association between emergency department (ED) involvement in cancer diagnosis and survival across cancer types in the Medicare population.
2026
·
Shannon Heitkamp
, Eric Olsen
, et al.
·
Cancer Research
·
1
Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-Based Tests for Early Cancer Detection
2025
·
Christina A. Clarke
, Breeana L. Mitchell
, et al.
·
Clinical Cancer Research
·
1
PDF
Data from Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches
2026
·
Mylynda Massart
, Sana Raoof
, et al.
Supplementary Figure S3 from Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches
2026
·
Mylynda Massart
, Sana Raoof
, et al.
Supplementary Figure S2 from Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches
2026
·
Mylynda Massart
, Sana Raoof
, et al.
Supplementary Figure S1 from Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches
2026
·
Mylynda Massart
, Sana Raoof
, et al.
Supplementary Figure S2 from Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study
2025
·
Catherine R. Marinac
, Charles H. McDonnell
, et al.
PDF
Supplementary Table S1 from Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study
2025
·
Catherine R. Marinac
, Charles H. McDonnell
, et al.
PDF
Supplementary Figure S1 from Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study
2025
·
Catherine R. Marinac
, Charles H. McDonnell
, et al.
PDF
Data from Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution following Multicancer Early Detection Testing in the PATHFINDER Study
2025
·
Catherine R. Marinac
, Charles H. McDonnell
, et al.
Supplementary Figure 2 from Modeled Benefit of Individual Cancer Signal Origin Prediction for Multi-Cancer Early Detection
2025
·
Eric A. Klein
, Timothy R. Church
, et al.
Show more works
View as search
Works count:
55
Citation count:
637
H-index:
9
I10-index:
9
Year
Topic
Type